Giuseppe Gullo

1.0k total citations
42 papers, 692 citations indexed

About

Giuseppe Gullo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Giuseppe Gullo has authored 42 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Giuseppe Gullo's work include HER2/EGFR in Cancer Research (18 papers), Cancer Treatment and Pharmacology (14 papers) and Advanced Breast Cancer Therapies (9 papers). Giuseppe Gullo is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Cancer Treatment and Pharmacology (14 papers) and Advanced Breast Cancer Therapies (9 papers). Giuseppe Gullo collaborates with scholars based in Ireland, Italy and United States. Giuseppe Gullo's co-authors include John Crown, Joyce O’Shaughnessy, Francesco Sclafani, Susan Kennedy, Martin Clynes, Naomi Walsh, Kieran Sheahan, Lorraine O’Driscoll, Wei Ooi and Armando Santoro and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Giuseppe Gullo

40 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Gullo Ireland 13 368 271 154 151 88 42 692
Shelly Seward United States 15 390 1.1× 298 1.1× 157 1.0× 116 0.8× 144 1.6× 34 898
Heather M. Shaw United Kingdom 13 352 1.0× 349 1.3× 116 0.8× 132 0.9× 43 0.5× 34 725
Andrew P. Sciallis United States 15 254 0.7× 225 0.8× 172 1.1× 162 1.1× 47 0.5× 39 770
Hideaki Mitsui Japan 18 320 0.9× 393 1.5× 206 1.3× 290 1.9× 51 0.6× 47 863
Armando Orlandi Italy 17 519 1.4× 192 0.7× 248 1.6× 248 1.6× 100 1.1× 90 879
Sherry Yang United States 10 305 0.8× 210 0.8× 115 0.7× 60 0.4× 65 0.7× 32 645
Budhi Singh Yadav India 13 240 0.7× 133 0.5× 272 1.8× 146 1.0× 89 1.0× 85 666
Angela Thornton United States 9 275 0.7× 322 1.2× 102 0.7× 66 0.4× 79 0.9× 10 707
Valérie Méresse France 13 335 0.9× 314 1.2× 90 0.6× 103 0.7× 46 0.5× 23 830

Countries citing papers authored by Giuseppe Gullo

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Gullo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Gullo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Gullo more than expected).

Fields of papers citing papers by Giuseppe Gullo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Gullo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Gullo. The network helps show where Giuseppe Gullo may publish in the future.

Co-authorship network of co-authors of Giuseppe Gullo

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Gullo. A scholar is included among the top collaborators of Giuseppe Gullo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Gullo. Giuseppe Gullo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hand, Fiona, et al.. (2021). Metastatic uveal melanoma: A valid indication for liver resection.. PubMed. 25(2). 1161–1165. 5 indexed citations
3.
Walsh, Naomi, Charlotte Andrieu, Peter O’Donovan, et al.. (2020). Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer. British Journal of Cancer. 123(8). 1219–1222. 4 indexed citations
4.
Walsh, Naomi, Cecily Quinn, Janice M. Walshe, et al.. (2020). 173P Clinical characteristics of long-term responders to anti-HER2 therapy in metastatic breast cancer: A review of the charactHER clinical data. Annals of Oncology. 31. S78–S78. 1 indexed citations
5.
Leoni, Chiara, Giuseppe Gullo, Nicoletta Resta, et al.. (2019). First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma. American Journal of Medical Genetics Part A. 179(7). 1319–1324. 33 indexed citations
6.
7.
8.
Greally, Megan, Niamh Coleman, Cecily Quinn, et al.. (2018). Where youth matters—clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer. Irish Journal of Medical Science (1971 -). 188(1). 59–67. 4 indexed citations
9.
Canonici, Alexandra, Neil T. Conlon, Kasper Pedersen, et al.. (2018). HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer. Investigational New Drugs. 37(3). 441–451. 21 indexed citations
10.
Gullo, Giuseppe, Naomi Walsh, D. Fennelly, et al.. (2018). Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project. British Journal of Cancer. 119(3). 374–380. 8 indexed citations
11.
Dunne, Mary, Moya Cunningham, Giuseppe Gullo, et al.. (2018). Uveal Melanoma in Ireland. Ocular Oncology and Pathology. 5(3). 195–204. 28 indexed citations
12.
Losurdo, Agnese, Giuseppe Gullo, Giovanna Masci, et al.. (2017). Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature. Critical Reviews in Oncology/Hematology. 113. 283–291. 36 indexed citations
13.
Lim, Marvin, et al.. (2017). Metastatic HER2+ Breast Cancer: A Potentially Curable Disease?. Cureus. 9(9). e1654–e1654. 3 indexed citations
14.
Murtagh, Gillian, Tomás G. Lyons, Eoin O’Connell, et al.. (2016). Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up. Breast Cancer Research and Treatment. 156(3). 501–506. 22 indexed citations
15.
Gullo, Giuseppe, Daniela Bettio, Monica Zuradelli, et al.. (2013). Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy. The Breast. 22(2). 190–193. 8 indexed citations
16.
Crown, John, Joyce O’Shaughnessy, & Giuseppe Gullo. (2012). Emerging targeted therapies in triple-negative breast cancer. Annals of Oncology. 23. vi56–vi65. 175 indexed citations
17.
Sclafani, Francesco, Giuseppe Gullo, Kieran Sheahan, & John Crown. (2012). BRAF mutations in melanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications. Critical Reviews in Oncology/Hematology. 87(1). 55–68. 54 indexed citations
18.
Walsh, Naomi, Annemarie Larkin, Susan Kennedy, et al.. (2009). Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma. BMC Urology. 9(1). 6–6. 73 indexed citations
19.
O’Driscoll, Lorraine, Naomi Walsh, A. Larkin, et al.. (2007). MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma.. PubMed. 27(4B). 2115–20. 52 indexed citations
20.
Rimassa, Lorenza, Giuseppe Gullo, Carlo Carnaghi, et al.. (2006). Chemotherapy with Mitomycin C and Capecitabine in Patients with Advanced Colorectal Cancer Pretreated with Irinotecan and Oxaliplatin. Tumori Journal. 92(4). 285–289. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shelly Seward Breakdown of academic impact, for papers by Heather M. Shaw Breakdown of academic impact, for papers by Andrew P. Sciallis Breakdown of academic impact, for papers by Hideaki Mitsui Breakdown of academic impact, for papers by Armando Orlandi Breakdown of academic impact, for papers by Sherry Yang Breakdown of academic impact, for papers by Budhi Singh Yadav Breakdown of academic impact, for papers by Angela Thornton Breakdown of academic impact, for papers by Valérie Méresse
Rankless by CCL
2026